查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947120

2026年全球性行為感染（STI）及陰道炎聚合酵素鏈鎖反應（PCR）檢測市場報告

Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場發展迅速，預計將從2025年的6.8億美元成長到2026年的7.5億美元，複合年成長率（CAGR）為10.3%。過去幾年的成長可歸因於多種因素，例如性行為感染的日益流行、傳統診斷方法的局限性、女性生殖健康意識的提高、臨床診斷檢查室的擴張以及標準PCR檢測通訊協定的採用。

預計未來幾年，性行為感染(STI) 和陰道炎聚合酵素鏈鎖反應(PCR) 檢測市場將強勁成長，到 2030 年市場規模將達到 10.8 億美元，複合年成長率 (CAGR) 為 9.5%。預測期內的成長要素包括：對照護現場分子診斷的需求不斷成長、多重 PCR 和即時PCR技術的進步、居家檢測解決方案的日益普及、分子診斷基礎設施投資的增加以及性行為感染和陰道炎篩檢計畫的擴展。預測期內的主要趨勢包括：用於性行為感染和陰道炎檢測的多重 PCR 檢測板的廣泛應用、對快速靈敏的分子診斷技術的日益青睞、對居家和自採樣 PCR檢測套組的需求不斷成長、PCR 檢測在女性常規健康檢查中的應用範圍擴大，以及對早期病原體準確鑑定的日益重視。

性健康篩檢頻率的不斷提高預計將推動性行為感染(STI) 和陰道炎聚合酵素鏈鎖反應(PCR) 檢測市場的成長。性行為感染傳染感染篩檢是一種醫學評估，旨在檢測性行為感染感染及相關疾病，從而實現早期診斷、適當治療和預防疾病傳播。篩檢增加的主要促進因素是全球性行為感染的上升，這凸顯了快速且準確檢測的必要性，以最大限度地減少併發症並遏制疾病的進一步傳播。 PCR 檢測在這方面發揮著至關重要的作用，因為它能夠準確識別病原體，即使是無症狀感染者也能檢測到，有助於早期療育。例如，根據英國政府官方網站 (GOV.UK) 的數據，截至 2025 年 6 月，英國新增性傳染感染病例數預計將從 2023 年的 399,947 例下降 8.8% 至 2024 年的 364,750 例，這反映了檢測力度加大帶來的正面影響。因此，性健康檢測的增加推動了性傳染感染和陰道炎 PCR 檢測市場的擴張。

性行為感染(STI) 和陰道炎 PCR 檢測市場的主要企業正在開發多重即時PCR檢測等技術，以滿足對快速、準確和全面的病原體檢測日益成長的需求。多重 PCR 可在單次檢測中同時擴增和鑑定多種病原體的 DNA 或 RNA，與傳統的單一病原體檢測相比，可縮短檢測週期並降低成本。此方法還提高了靈敏度和特異性，能夠檢測到傳統培養沙眼披衣菌顯微鏡檢查可能遺漏或難以檢測的低濃度病原體遺傳物質（包括合併感染）。例如，2023 年 2 月，美國生物技術公司 Thermo Fisher Scientific 推出了 Applied Biosystems Trumark STI Select Panel，這是一種多重即時即時PCR檢測，可同時檢測四種主要的性行為感染：黴漿菌和生殖支原體。該測試是為研究目的而開發的，代表了分子性傳播感染診斷的重大進步，可提供更快、更靈敏的診斷，並最佳化檢查室工作流程以改善臨床結果。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球性行為感染（STI）及陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 多重PCR檢測板在性行為感染傳染病和陰道炎檢測的應用日益廣泛
    • 對快速靈敏的分子診斷的需求日益成長
    • 家用和自採樣PCR檢測套組的需求不斷成長
    • 在女性常規健康檢查中擴大PCR檢測範圍
    • 越來越重視早期準確識別病原體

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 居家醫療或家庭檢測服務提供者
  • 公共衛生和篩檢項目
  • 研究和學術機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場規模、比較和成長率分析
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場表現：規模和成長，2020-2025年
  • 全球性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場預測：規模和成長，2025-2030年，2035年

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按測試類型
  • 性行為感染傳染病（STR）聚合酵素鏈鎖反應（PCR）檢測組，陰道炎聚合酵素鏈鎖反應（PCR）檢測組
  • 因疾病
  • 性行為感染傳染病、陰道感染疾病
  • 最終用戶
  • 醫院/診所、診斷檢查室、居家醫療或家庭檢測以及其他最終用戶
  • 按類型細分：性行為感染傳染病（STR）聚合酵素鏈鎖反應（PCR）檢測組
  • 披衣菌感染衣原體聚合酵素鏈鎖反應、淋病聚合酵素鏈鎖反應、陰道毛滴蟲聚合酵素鏈鎖反應、單純皰疹病毒聚合酵素鏈鎖反應、人類乳突病毒聚合酵素鏈鎖反應、黴漿菌支原體聚合酵素鏈鎖反應、梅毒聚合酵素鏈鎖反應、多重性性行為感染聚合酵素鏈鎖反應檢測
  • 按類型細分：陰道炎聚合酵素鏈鎖反應(PCR) 檢測組
  • 細菌性陰道炎聚合酵素鏈鎖反應、念珠菌性聚合酵素鏈鎖反應聚合酵素鏈鎖反應、滴蟲性陰道炎聚合酶鍊式反應、混合性陰道炎聚合酵素鏈鎖反應檢測、需氧性陰道炎聚合酵素鏈鎖反應、萎縮性陰道炎聚合酵素鏈鎖反應

第10章 區域與國家分析

  • 全球性行為感染（STI）及陰道炎聚合酵素鏈鎖反應（PCR）檢測市場按地區分類、績效及預測（2020-2025年、2025-2030年、2035年）
  • 全球性行為感染（STI）及陰道炎聚合酵素鏈鎖反應（PCR）檢測市場依國家/地區分類、績效及預測（2020-2025年、2025-2030年、2035年）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：競爭格局和市場佔有率，2024年
  • 性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：公司估值矩陣
  • 性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Becton Dickinson and Company

第37章：其他領先和創新企業

  • Hologic Inc., QIAGEN NV, ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC SL, ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：提供新機會的國家
  • 2030年性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：提供新機會的細分市場
  • 2030年性行為感染（STI）和陰道炎聚合酵素鏈鎖反應（PCR）檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MSTIS02_G26Q1

Sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing is a highly accurate molecular diagnostic technique that amplifies and detects the genetic material of pathogens responsible for sexually transmitted and vaginal infections. This method allows for rapid identification of bacteria, viruses, and other microorganisms, enabling healthcare providers to diagnose infections effectively and customize treatments.

The primary test types for STI and vaginitis PCR testing include STI PCR panels and vaginitis PCR panels. STIs are infections caused by bacteria, viruses, fungi, or parasites, primarily transmitted through sexual contact, including vaginal, anal, and oral sex. These tests cover a broad spectrum of sexually transmitted and vaginal infections and are used by various end users such as hospitals and clinics, diagnostic laboratories, and homecare or at-home testing services.

Tariffs are impacting the sti and vaginitis pcr testing market by increasing the cost of imported reagents, pcr instruments, and molecular consumables, thereby raising overall testing expenses. Diagnostic laboratories and homecare testing segments are particularly affected, with asia-pacific and emerging markets facing higher import duties on molecular diagnostics. These cost pressures have led to pricing adjustments and slower adoption in cost-sensitive regions. However, tariffs have also encouraged local manufacturing of pcr kits and reagents, fostering regional self-reliance and strengthening domestic diagnostic capabilities.

The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market statistics, including sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing industry global market size, regional shares, competitors with a sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market share, detailed sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing industry. This sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market size has grown rapidly in recent years. It will grow from $0.68 billion in 2025 to $0.75 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing prevalence of sexually transmitted infections, limitations of traditional diagnostic methods, growing awareness of women's reproductive health, expansion of clinical diagnostic laboratories, adoption of standard pcr testing protocols.

The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market size is expected to see strong growth in the next few years. It will grow to $1.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rising demand for point-of-care molecular diagnostics, technological advancements in multiplex and real-time pcr, increasing adoption of home-based testing solutions, growing investments in molecular diagnostic infrastructure, expanding screening programs for sti and vaginitis. Major trends in the forecast period include rising adoption of multiplex pcr panels for sti and vaginitis detection, increasing preference for rapid and high-sensitivity molecular diagnostics, growing demand for at-home and self-collected pcr testing kits, expansion of pcr testing in routine women's health screening, enhanced focus on early and accurate pathogen identification.

The rising frequency of sexual health screenings is expected to drive growth in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market. Sexual health screenings are medical evaluations performed to detect STIs and related conditions, enabling early diagnosis, timely treatment, and prevention of disease transmission. The increase in screenings is largely due to the global rise in STIs, which underscores the need for prompt and accurate detection to minimize complications and curb further spread. PCR testing plays a vital role in this context by allowing precise identification of pathogens, often even in asymptomatic individuals, facilitating early intervention. For instance, in June 2025, according to GOV.UK, new STI diagnoses in the UK declined by 8.8%, from 399,947 cases in 2023 to 364,750 cases in 2024, reflecting the impact of enhanced screening efforts. Therefore, the growth in sexual health screenings is propelling the expansion of the STI and vaginitis PCR testing market.

Major players in the sexually transmitted infection (STI) and vaginitis PCR testing market are developing technologies like multiplex real-time PCR assays to meet the increasing demand for fast, precise, and comprehensive pathogen detection. Multiplex PCR allows for the simultaneous amplification and identification of DNA or RNA from multiple pathogens within a single test, lowering both turnaround time and costs compared to traditional single-pathogen assays. This method also enhances sensitivity and specificity, enabling the detection of low levels of pathogen genetic material-even in co-infections-that conventional culture or microscopy techniques might overlook or detect less accurately. For instance, in February 2023, Thermo Fisher Scientific, a US-based biotechnology company, introduced the Applied Biosystems TrueMark STI Select Panel, a multiplex real-time PCR assay designed to concurrently detect four prevalent STIs: Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. Intended for research purposes, this test improves clinical outcomes by offering faster, highly sensitive diagnostics while optimizing laboratory workflows, marking a notable advancement in molecular STI diagnostics.

In December 2024, OraSure Technologies, a US-based medical device and diagnostics company, acquired Sherlock Biosciences for an undisclosed sum. Through this acquisition, OraSure seeks to broaden its molecular diagnostics offerings in sexual health by incorporating Sherlock's rapid, self-collected STI testing solutions and advancing its entry into the over-the-counter diagnostics market. Sherlock Biosciences, also based in the US, specializes in PCR-based testing for sexually transmitted infections (STIs) and vaginitis.

Major companies operating in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., Bioperfectus Technologies Co. Ltd.

North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2025. The regions covered in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market consists of revenues earned by entities by providing services such as clinical consultations, comprehensive screening tests, multiplex testing, treatment monitoring, and sample collection guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market also includes sales of nucleic acid extraction kits, positive and negative control materials, automated PCR analyzers, and single-pathogen PCR test kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels; Vaginitis Polymerase Chain Reaction (PCR) Panels
  • 2) By Condition: Sexually Transmitted Infections; Vaginal Infections
  • 3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Or At-Home Testing; Other End Users
  • Subsegments:
  • 1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction; Neisseria Gonorrhoeae Polymerase Chain Reaction; Trichomonas Vaginalis Polymerase Chain Reaction; Herpes Simplex Virus Polymerase Chain Reaction; Human Papillomavirus Polymerase Chain Reaction; Mycoplasma Genitalium Polymerase Chain Reaction; Syphilis Polymerase Chain Reaction; Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
  • 2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction; Candida Species Polymerase Chain Reaction; Trichomoniasis Polymerase Chain Reaction; Mixed Vaginitis Polymerase Chain Reaction Panels; Aerobic Vaginitis Polymerase Chain Reaction; Atrophic Vaginitis Polymerase Chain Reaction
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company; Hologic Inc.; QIAGEN N.V.; ARUP Laboratories Inc.; Seegene Inc.; LetsGetChecked Ltd.; Sansure Biotech Inc.; Visby Medical Inc.; R-Biopharm AG; Savyon Diagnostics Ltd.; altona Diagnostics GmbH; SpeeDx Pty Ltd.; CERTEST BIOTEC S.L.; ALPCO Diagnostics; Atila Biosystems Inc.; Ridacom Diagnostics Ltd.; Sinochips Diagnostics Co Ltd.; Vitassay S.L.; Bioperfectus Technologies Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Multiplex Pcr Panels For Sti And Vaginitis Detection
    • 4.2.2 Increasing Preference For Rapid And High-Sensitivity Molecular Diagnostics
    • 4.2.3 Growing Demand For At-Home And Self-Collected Pcr Testing Kits
    • 4.2.4 Expansion Of Pcr Testing In Routine Women'S Health Screening
    • 4.2.5 Enhanced Focus On Early And Accurate Pathogen Identification

5. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Homecare Or At-Home Testing Providers
  • 5.4 Public Health And Screening Programs
  • 5.5 Research And Academic Institutes

6. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Segmentation

  • 9.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, Vaginitis Polymerase Chain Reaction (PCR) Panels
  • 9.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sexually Transmitted Infections, Vaginal Infections
  • 9.3. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Homecare Or At-Home Testing, Other End Users
  • 9.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chlamydia Trachomatis Polymerase Chain Reaction, Neisseria Gonorrhoeae Polymerase Chain Reaction, Trichomonas Vaginalis Polymerase Chain Reaction, Herpes Simplex Virus Polymerase Chain Reaction, Human Papillomavirus Polymerase Chain Reaction, Mycoplasma Genitalium Polymerase Chain Reaction, Syphilis Polymerase Chain Reaction, Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
  • 9.5. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Vaginitis Polymerase Chain Reaction (PCR) Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bacterial Vaginosis Polymerase Chain Reaction, Candida Species Polymerase Chain Reaction, Trichomoniasis Polymerase Chain Reaction, Mixed Vaginitis Polymerase Chain Reaction Panels, Aerobic Vaginitis Polymerase Chain Reaction, Atrophic Vaginitis Polymerase Chain Reaction

10. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Regional And Country Analysis

  • 10.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 11.1. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 12.1. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 13.1. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 14.1. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 15.1. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 16.1. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 17.1. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 18.1. Taiwan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 19.1. South East Asia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 20.1. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 21.1. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 22.1. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 23.1. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 24.1. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 25.1. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 26.1. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 27.1. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 28.1. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 29.1. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 30.1. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 31.1. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 32.1. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 33.1. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 34.1. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Regulatory and Investment Landscape

36. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Company Profiles

  • 36.1. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Other Major And Innovative Companies

  • Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd.

38. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

40. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer